Answers are grounded in this paper and cite their sources.
). However, their application as screening and diagnostic tools, particularly for early-stage CRC, has not been fully optimized, and their effectiveness needs validation in large, multi-center patient populations. Extensive trials and further investigation are required to translate genetic and epigenetic biomarkers into practical clinical use. biomarkers, diagnostic biomarkers.
No takes yet. Share an insight, caveat, or question.
Miftahussurur et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: